JC
J Martin Carroll
Director

J Martin Carroll insider trades: Esperion Therapeutics (ESPR) stock buys and sales

Director, Esperion Therapeutics Last trade May 11, 2023 59 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2013
9
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where J reports to the SEC

and 3 more companies

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 11, 2023ESPR↑ Buy$49K
Jun 2, 2022ESPR↑ Buy$28K
Mar 12, 2021MNKKQ↓ Sell$13K
Mar 12, 2021MNKKQ↓ Sell$4K
Nov 9, 2017MNK↑ Buy$102K
May 13, 2016ITEK↑ Buy$90K
May 8, 2015TXMD↑ Buy$61K
Aug 12, 2014MNK↑ Buy$138K
Nov 26, 2013MNK↑ Buy$103K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ESPR insiders

Open-market trades in the last 12 months

About J Martin Carroll's insider trades

J Martin Carroll is a director at Esperion Therapeutics (ESPR). Since Nov 26, 2013, J has reported 7 open-market purchases worth $572K and 2 sales worth $17K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (40 filings), shares withheld for taxes (8 filings), gifts (4 filings), other transactions (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ESPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.